Feb 3, 2012 5:08 AM PST
It has been a good start to the year for many micro and small cap biotech stocks with a few FDA approvals lifting the sector in general. With the prospect of an economic recovery, and investors looking for greater returns, many under-funded (and historically...
0 Comment(s)
